脾脏关闭征:氮-13氨PET心肌灌注显像中腺苷反应的新标志物
结果显示,CMR SSO阳性患者的PET脾脏信号活性比(SAR)中位数显著低于SSO阴性患者,提示PET MPI可检测SSO,有助于区分腺苷无反应者与真正MFR受损患者。
要点
- 氮-13氨PET MPI可检测腺苷诱导的脾脏关闭征,与CMR标准参照一致。
- CMR SSO阳性者PET脾脏SAR中位数显著低于SSO阴性者。
- SSO或有助于区分腺苷无反应者与真正MFR受损患者。
核心结论
- 与CMR类似,氮-13氨PET MPI可检测腺苷诱导的脾脏关闭征。
- 该征象可能有助于区分腺苷无反应者与因微血管功能障碍或多支冠状动脉病变导致真正MFR受损的患者。
研究设计与样本
- CMR中SSO通过视觉评估(阳性 vs 阴性)和定量计算脾脏负荷/静息峰值信号强度比(SIR)评估。
- PET MPI中脾脏信号活性比(SAR)计算为脾脏负荷/静息最大标准摄取值之比。
主要发现
- CMR SSO阳性患者的中位SIR显著低于SSO阴性患者(0.57 [IQR 0.49 to 0.62] vs 0.89 [IQR 0.76 to 0.98];P < .001)。
- PET MPI中,CMR SSO阳性患者的中位SAR显著低于SSO阴性患者(0.40 [IQR 0.32 to 0.45] vs 0.80 [IQR 0.47 to 0.98];P < .001)。
临床怎么用
- 在氮-13氨PET MPI中可参考脾脏SAR评估腺苷反应,辅助判断MFR降低是否由腺苷反应不足所致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: No methodology is available to distinguish truly reduced myocardial flow reserve (MFR) in positron emission tomography myocardial perfusion imaging (PET MPI) from seemingly impaired MFR due to inadequate adenosine response. The adenosine-induced splenic switch-off (SSO) sign has been proposed as a potential marker for adequate adenosine response in cardiac magnetic resonance (CMR). We assessed the feasibility of detecting SSO in nitrogen-13 ammonia PET MPI using SSO in CMR as the standard of reference. METHODS AND RESULTS: Fifty patients underwent simultaneous CMR and PET MPI on a hybrid PET/MR device with co-injection of a gadolinium-based contrast agent and nitrogen-13 ammonia during rest and adenosine-induced stress. In CMR, SSO was assessed visually (positive vs negative SSO) and quantitatively by calculating the ratio of the peak signal intensity of the spleen during stress over rest (SIR). In PET MPI, the splenic signal activity ratio (SAR) was calculated as the maximal standard uptake value of the spleen during stress over rest. The median SIR was significantly lower in patients with positive versus negative SSO in CMR (0.57 [IQR 0.49 to 0.62] vs 0.89 [IQR 0.76 to 0.98]; P < .001). Similarly, median SAR in PET MPI was significantly lower in patients with positive versus negative SSO (0.40 [IQR 0.32 to 0.45] vs 0.80 [IQR 0.47 to 0.98]; P < .001). CONCLUSION: Similarly to CMR, SSO can be detected in nitrogen-13 ammonia PET MPI. This might help distinguish adenosine non-responders from patients with truly impaired MFR due to microvascular dysfunction or multivessel coronary artery disease.
引用
- Bakula A, Patriki D, von Felten E, et al. Splenic switch-off as a novel marker for adenosine response in nitrogen-13 ammonia PET myocardial perfusion imaging: Cross-validation against CMR using a hybrid PET/MR device. J Nucl Cardiol. 2020. PMID: 33354759. doi:10.1007/s12350-020-02448-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。